Dani Paul Bolognesi
Chief Executive Officer at B3 Bio, Inc.
Network origin in Dani Paul Bolognesi first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Trimeris, Inc.
 Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC.
18
| Extinct | Pharmaceuticals: Major | 18 |
Senex Biotechnology, Inc.
 Senex Biotechnology, Inc. BiotechnologyHealth Technology Senex Biotechnology, Inc. is a drug discovery and development company focused on oncology therapeutics. The company was founded by Igor B. Roninson and is headquartered in Columbia, SC.
4
| Holding Company | Biotechnology | 4 |
Istari Oncology, Inc.
 Istari Oncology, Inc. BiotechnologyHealth Technology Istari Oncology, Inc. operates as a clinical-stage biotechnology company. It focuses on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. Its core technology assets are PVS-RIPO, a prototypic oncolytic recombinant polio virus vaccine, and a series of antibody-drug conjugates comprising antibodies or antibody fragments to a variety of oncology targets. The company was founded by Darell D. Bigner and Matthias Gromeier in 2016 and is headquartered in Research Triangle Park, NC.
4
| Holding Company | Biotechnology | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Dani Paul Bolognesi via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| HERON THERAPEUTICS, INC. | Biotechnology | Chairman | |
| E I DU PONT DE NEMOURS AND CO | Chemicals: Agricultural | General Counsel Corporate Officer/Principal | |
| INCYTE CORPORATION | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| RESPIRERX PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member | |
| LA JOLLA PHARMACEUTICAL COMPANY | Pharmaceuticals: Major | Chairman | |
| SALIX PHARMACEUTICALS, LTD. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
Deutsche Bank Securities, Inc.
 Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Deutsche Bank Securities, Inc. (DBSI) is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 1971 and is a wholly-owned investment banking and brokerage arm of DB U.S. Financial Markets Holding Corp., ultimately held by Deutsche Bank AG (NYSE: DB, FRA: DBK) in Germany. DBSI provides securities brokerage and investment advisory services to domestic and international private clients and institutions. They are also a primary dealer in US government securities as designated by the Federal Reserve. | Investment Banks/Brokers | Corporate Officer/Principal | |
| LIPOSCIENCE INC | Medical Specialties | Chairman Founder | |
Tang Capital Management LLC
 Tang Capital Management LLC Investment ManagersFinance Tang Capital Management LLC (Tang Capital) is an independent hedge fund manager headquartered in San Diego, California. The firm was founded by Kevin Tang in 2002. Tang Capital provides investment advice to high-net-worth clients. | Investment Managers | Chief Executive Officer | |
Baker Bros. Advisors LP
 Baker Bros. Advisors LP Investment ManagersFinance Baker Bros. Advisors LP (BBA) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Julian Baker and Felix Baker in 2000 and do-business-as Baker Brothers Investments. BBA serves as a discretionary investment advisor to pooled investment vehicles operating as private investment funds and to a managed account. | Investment Managers | Founder Founder | |
| GENOMIC HEALTH, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
| REATA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| TETRAPHASE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
eXIthera Pharmaceuticals, Inc.
 eXIthera Pharmaceuticals, Inc. BiotechnologyHealth Technology eXIthera Pharmaceuticals, Inc. develops and manufactures stroke prevention and antithrombosis drugs. Its drugs are based on the pathophysiological role of Factor XI in the initiation of intravascular thrombi without causing undue bleeding. The firm’s drug candidates are small, orally active, and highly selective Factor XI inhibitors. The company was founded by Neil J. Hayward and Frans L. Stassen in 2012 and is headquartered in Westborough, MA. | Biotechnology | Director/Board Member | |
| Baker Bros. Advisors GP LLC | Corporate Officer/Principal Corporate Officer/Principal | ||
Velosal Medical, Inc.
 Velosal Medical, Inc. Medical DistributorsDistribution Services Velosal Medical, Inc. designs, develops, and markets medical devices. It develops a video guided laryngoscope for tracheal intubations in order to visualize the airway when placing an endotracheal tube. The company is headquartered in Cary, NC. | Medical Distributors | Chairman | |
| GSK PLC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Sales & Marketing | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree | |
| FBB Associates | Corporate Officer/Principal Corporate Officer/Principal | ||
Deutsche Bank Alex. Brown, Inc.
 Deutsche Bank Alex. Brown, Inc. Financial ConglomeratesFinance Deutsche Bank Alex Brown, Inc. provides wealth management services. The company was founded in 2000 and is headquartered in Baltimore, MD. | Financial Conglomerates | Corporate Officer/Principal | |
| OCERA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member | |
| Temple University (Pennsylvania) | College/University | Doctorate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree | |
| University of California, Santa Barbara | College/University | Doctorate Degree | |
Nexus Therapeutics, Inc.
 Nexus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of NB Therapeutics, Nexus Therapeutics, Inc. is a company that provides biopharmaceutical management services. The company is based in Framingham, MA. The CEO of the company is Dennis I. Goldberg. Nexus Therapeutics was acquired by Transport Pharmaceuticals, Inc. on August 14, 2006. | Miscellaneous Commercial Services | Chief Executive Officer | |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | Director/Board Member Founder | |
National Association of Corporate Directors (Virginia)
 National Association of Corporate Directors (Virginia) Miscellaneous Commercial ServicesCommercial Services National Association of Corporate Directors provides online and print information services to directors of public companies. It offers in-boardroom education, evaluation, governance reviews, board composition and succession planning, board recruitment, ongoing advisory, insights, and analytics services. The company was founded in 1977 and is headquartered in Arlington, VA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Presidio Pharmaceuticals, Inc.
 Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Presidio Pharmaceuticals, Inc. discovers and develops small-molecule antiviral therapeutics. Its products in pipeline include NS5A, PPI-668 and PPI-383 for treating hepatitis C virus infections. The company was founded by Omar K. Haffar, Antoun Nabhan and David V. Jobes in March 2006 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member | |
| Glaxo, Inc. | Chairman Corporate Officer/Principal | ||
| The University of North Carolina at Charlotte | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree Corporate Officer/Principal Graduate Degree Masters Business Admin | |
| JOUNCE THERAPEUTICS, INC. | Miscellaneous Commercial Services | Chief Executive Officer | |
| PRELUDE THERAPEUTICS INCORPORATED | Biotechnology | Director/Board Member Director/Board Member | |
| MADRIGAL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| TALIS BIOMEDICAL CORPORATION | Medical Specialties | Chairman Director/Board Member | |
| KYMERA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| ODONATE, INC. | Pharmaceuticals: Major | Chief Executive Officer |
Statistics
International
| United States | 47 |
| Canada | 3 |
| United Kingdom | 2 |
Sectoral
| Health Technology | 29 |
| Commercial Services | 6 |
| Consumer Services | 6 |
| Finance | 5 |
| Process Industries | 2 |
Operational
| Director/Board Member | 134 |
| Corporate Officer/Principal | 59 |
| Independent Dir/Board Member | 39 |
| Chairman | 34 |
| President | 29 |
Most connected contacts
| Insiders | |
|---|---|
| Charlie Sanders | 38 |
| Felix Baker | 28 |
| Julian Baker | 20 |
| Sean Nolan | 18 |
| Kevin Tang | 18 |
| Steven Skolsky | 17 |
| Robert R. Bonczek | 17 |
| Richard A. Franco | 17 |
| Diego Miralles | 14 |
| E. Gary Cook | 14 |
| Walter Capone | 11 |
| Timothy J. Creech | 11 |
| Dennis I. Goldberg | 11 |
| M. Ross Johnson | 10 |
| Victor Sandor | 9 |
- Stock Market
- Insiders
- Dani Paul Bolognesi
- Company connections
